SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $200,000 | -10.3% | 6,198 | -14.3% | 0.02% | +5.9% |
| Q2 2021 | $223,000 | +10.4% | 7,230 | -6.4% | 0.02% | +6.2% |
| Q1 2021 | $202,000 | -46.3% | 7,727 | -28.0% | 0.02% | -46.7% |
| Q1 2019 | $376,000 | +36.7% | 10,735 | +71.3% | 0.03% | +76.5% |
| Q3 2018 | $275,000 | -69.1% | 6,266 | -57.8% | 0.02% | -68.5% |
| Q2 2018 | $890,000 | +256.0% | 14,863 | +172.7% | 0.05% | +315.4% |
| Q1 2018 | $250,000 | -32.6% | 5,451 | -36.7% | 0.01% | -38.1% |
| Q2 2017 | $371,000 | – | 8,607 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |